DLGAP1 and colorectal carcinoma: Moreover, DLGAP1-AS2 depletion increased, whereas ectopic DLGAP1-AS2 expression decreased the half-life of ELOA protein in CRC cells treated with the protein synthesis inhibitor cycloheximide (CHX) (Fig. 5B and Fig.S8A).